TSX •
Healthcare •
Biotechnology •
Quote as of 07/22/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSX
Market Capitalization1.99 mln
Float118 mln
Earnings Date08/14/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-45.74
Highly reliable
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
-0.76
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Appili Therapeutics is a Canadian company founded in 2015 and based in Halifax, focused on finding and developing new treatments for infectious diseases that currently lack good options. Its pipeline includes three key products: a child-friendly liquid form of the antibiotic metronidazole, a topical treatment for a parasitic skin disease called cutaneous leishmaniasis, and a vaccine targeting a rare but dangerous bacterial infection known as tularemia.
